The financial outlook for the digital health sector is less than ideal, characterized by lower funding amounts, shrinking valuations, dwindling profitability and the collapse of Silicon Valley Bank. During a recent conference panel, four healthcare VCs discussed their reactions to this. They explained why the market has switched its focus from growth to value, as well gave advice to startups about what they need to know in this changing environment.
Atropos Health — a company that delivers clinical data to physicians at the point of care to help them treat complex patients — recently launched a clinical advisory board and new evidence network. Both announcements are meant to enhance the credibility and transparency of its physician consult platform, CEO Brigham Hyde said at ViVE in Nashville.
Demand for alternative drug delivery methods has the potential to reshape therapeutic markets and improve clinical outcomes. New innovations, especially oral alternatives, are poised to drive broad changes across the entire sector.
Johnson & Johnson's pullback from RSV research thins the pack of companies aiming to develop a vaccine for the pathogen. GSK and Pfizer have vaccines under FDA review and a shot from Moderna could soon follow.
As many as 25 million Americans over the age of five say they speak English "less than well" — that's nearly a tenth of the country. Contrast that with the fact that nearly one third of American hospitals don't provide interpreters to patients who speak little English, even though it is required by federal law. Only 13 states and Washington, D.C. provide reimbursements for the cost of medical interpreters through Medicaid.
No comments